SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-048342
Filing Date
2022-09-01
Accepted
2022-09-01 18:19:00
Documents
2
Period of Report
2022-09-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 13528
2 POA DOCUMENT poa.txt EX-24 3051
  Complete submission text file 0001209191-22-048342.txt   18188
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Issuer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DRIVE, STE 300 SAN DIEGO CA 92130
Business Address
Cline Christopher R. (Reporting) CIK: 0001943192 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36257 | Film No.: 221222662